Judge Says Aggregation of Medical Monitoring Costs Inappropriate, Remands Cases




LOS ANGELES - A federal judge in California has remanded two Vioxx-related medical monitoring class actions, determining that defendant Merck & Co. failed to demonstrate that the damages sought by plaintiffs - either current or prospective - would exceed the jurisdictional limit. Pargar v. Merck & Company, Inc., et al., No. 04-9206; Bloom-Thomen v. Merck & Company, Inc., et al., No. 04-9245 (C.D. Calif.).

In orders issued Jan. 3, Judge John F. Walter of the U.S. District Court for the Central District of California rejected Merck's argument that the cost to start up a medical monitoring fund for plaintiffs who …






UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Water Contamination Litigation Presented by EisnerAmper

May 06, 2025

MORE DETAILS



HarrisMartin's MDL Conference

March 26, 2025 - Charlotte, NC
Omni Charlotte Hotel

MORE DETAILS